Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q6YN16
UPID:
HSDL2_HUMAN
Alternative names:
Short chain dehydrogenase/reductase family 13C member 1
Alternative UPACC:
Q6YN16; A8K1L4; A8K8X1; A8MSV3; Q658M8; Q9BT58
Background:
Hydroxysteroid dehydrogenase-like protein 2, also known as Short chain dehydrogenase/reductase family 13C member 1, is characterized by its apparent lack of steroid dehydrogenase activity. This unique feature distinguishes it within the enzyme family, suggesting a specialized yet to be understood role in cellular processes.
Therapeutic significance:
Understanding the role of Hydroxysteroid dehydrogenase-like protein 2 could open doors to potential therapeutic strategies. Its unique enzymatic profile hints at untapped avenues for drug discovery, emphasizing the importance of further research in elucidating its function.